B and T Cell Response after Third Dose of SARS-CoV2 Vaccine in Kidney Transplant Patients

Sailender13 Apr, 2022Health

Kidney transplant recipients (KTR) receiving immunosuppressive medication exhibit reduced immune responses after mRNA-based vaccination. In order to address this clinical challenge, a third vaccination for solid organ transplant recipients has recently become standard of care. In the current study, we evaluate the effectiveness of a third vaccination dose of either heterologous ChAdOx1 (Vaxzevria) or homologous BNT162b2 (Comirnaty) in 25 KTR patients.